DYMISTA
Generic: AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE
Viatris Specialty LLCManufacturer
NASALRoute
AZELASTINE HYDROCHLORIDEActive Substance
2012-05-01Original Approval
DYMISTA is FDA application NDA202236, sponsored by MYLAN SPECIALITY LP. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
ASTHMA
14 reports
2
PRODUCTIVE COUGH
14 reports
3
DYSPNOEA
13 reports
4
PNEUMONIA
12 reports
5
CONDITION AGGRAVATED
11 reports
6
COUGH
11 reports
7
LACRIMATION INCREASED
11 reports
8
NASAL POLYPS
11 reports
9
PRODUCT USE IN UNAPPROVED INDICATION
11 reports
10
RESPIRATORY TRACT INFECTION
11 reports